Dr. Jason M. Vanatta, MD

Dr. Vanatta practices at Jewish Hospital and St Mary's Healthcare - HOPD in Louisville, Kentucky.

Dr. Vanatta's NPI, 1366452484, was assigned on August 9, 2006. Dr. Vanatta graduated from Drexel University College of Medicine in 2000. Dr. Vanatta holds Tennessee license 42475.

Dr. Vanatta's primary practice is Jewish Hospital and St Mary's Healthcare - HOPD, at 200 Abraham Flexner Way, Louisville, KY 40202.

Dr. Vanatta's primary practice is Jewish Hospital and St Mary's Healthcare - HOPD in Louisville, Kentucky. Dr. Vanatta is also affiliated with UofL Health - Jewish Hospital. The medical group on file is UofL Physicians, Radiology. Dmand AI also links Dr. Vanatta to 1 more hospital and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Vanatta practices, 3 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Vanatta's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dmand AI has Dr. Vanatta's licenses on file in 2 states: Tennessee and California.

CMS data shows 12 Medicare services from Dr. Vanatta across 1 procedure code in 2024, for 39 Medicare patients. Medicare paid $1,143 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 39 Medicare patients who saw Dr. Vanatta in 2024. The largest group is 65 to 74, with 18 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 36% are also on Medicaid. Their average risk score is 6.44, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Vanatta's median patient age at 63, with 47% women.

In 2024, Dr. Vanatta wrote 222 Medicare Part D claims for 40 patients. 86% of them were for generic drugs. CMS names the drug for 123 of them, across 6 drugs with 11 or more claims each, at $17,646 in total drug cost. In 2023, CMS named 271 claims across 12 drugs.

Dr. Vanatta accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 32 papers to Dr. Vanatta, published from 2013 to 2024. 2013 was the busiest year, with 4. The most frequent topics are Liver Transplantation, Graft Rejection and Liver Cirrhosis. Dr. Vanatta has published most often in Exp Clin Transplant. Dr. Vanatta's most frequent co-authors are James D. Eason, MD, Satheesh Padmanabhan Nair, MD and Ryan A. Helmick, MD.

Dmand AI links Dr. Vanatta to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Carcinoma, Hepatocellular and Liver Neoplasms.

CMS Open Payments shows 17 general payments to Dr. Vanatta from 9 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 92% of the total. XVIVO Perfusion Inc. paid the most, $1,008. It also lists 1 research payment totaling $1,125 in 2025.

Dr. Vanatta graduated from Drexel University College of Medicine in 2000.